N-(6-bromo-4-hydroxypyrido[2,3-d]pyrimidin-2-yl)pivalamide
95%
- Product Code: 219133
CAS:
116387-22-5
Molecular Weight: | 325.16 g./mol | Molecular Formula: | C₁₂H₁₃BrN₄O₂ |
---|---|---|---|
EC Number: | MDL Number: | ||
Melting Point: | Boiling Point: | ||
Density: | Storage Condition: | Room temperature |
Product Description:
Used as a key intermediate in the synthesis of kinase inhibitors, particularly in the development of anticancer agents. It exhibits potential in targeting protein kinases involved in cell proliferation and survival pathways. Its structural features allow for high selectivity and binding affinity in drug candidates, making it valuable in medicinal chemistry for optimizing lead compounds. Commonly employed in research settings to design molecules with improved pharmacokinetic properties and biological activity.
Sizes / Availability / Pricing:
Size | Availability | Price | Quantity |
---|---|---|---|
100mg | 10-20 days | ฿9,000.00 |
+
-
|
250mg | 10-20 days | ฿15,000.00 |
+
-
|
1g | 10-20 days | ฿30,000.00 |
+
-
|
N-(6-bromo-4-hydroxypyrido[2,3-d]pyrimidin-2-yl)pivalamide
Used as a key intermediate in the synthesis of kinase inhibitors, particularly in the development of anticancer agents. It exhibits potential in targeting protein kinases involved in cell proliferation and survival pathways. Its structural features allow for high selectivity and binding affinity in drug candidates, making it valuable in medicinal chemistry for optimizing lead compounds. Commonly employed in research settings to design molecules with improved pharmacokinetic properties and biological activity.
Mechanism | - |
Appearance | - |
Longevity | - |
Strength | - |
Storage | - |
Shelf Life | - |
Allergen(s) | - |
Dosage (Range) | - |
Recommended Dosage | - |
Dosage (Per Day) | - |
Recommended Dosage (Per Day) | - |
Mix Method | - |
Heat Resistance | - |
Stable in pH range | - |
Solubility | - |
Product Types | - |
INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :